Tag Archive for: QALYs
https://pioneerinstitute.org/wp-content/uploads/Untitled-design-2021-12-06T120924.383.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-12-06 11:44:202021-12-06 12:10:01The Promise and Challenges of Rare Cancer Treatments
Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-26.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-06-08 09:46:532021-06-08 09:49:03Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?
Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.
https://pioneerinstitute.org/wp-content/uploads/Green-Grunge-Basketball-Quote-UAAP_NCAA-Twitter-Post-1.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-04-02 06:00:242020-12-11 13:28:28New Report: Quality Adjusted Life Years (QALY) Methodology Discriminates Against Older Americans, Threatens to Deny Seniors Access to Life-Saving Care
New report asserts that with older americans more vulnerable during the COVID-19 pandemic, all health plans should avoid using the QALY methodology when assessing the value of care for older patients
https://pioneerinstitute.org/wp-content/uploads/1140-man-wheelchair-disability-aarp.imgcache.rev5804edef486e77e680d3985a3ddb67dd.jpg 655 1140 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-02-10 07:00:262021-01-28 15:07:32New Report & Legal Analysis Suggests ICER’s Quality Adjusted Life Years Methodology Violates the Americans with Disabilities Act
A new report, "The Legality of QALY under the ADA," outlines several potential legal violations and negative implications for disabled individuals related to the adoption of the QALY approach to drug value assessment, used most prominently by ICER.
https://pioneerinstitute.org/wp-content/uploads/questionmark-of-pills.jpg 599 900 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-06-24 00:01:552019-07-31 15:57:22New Report Addresses Distinct Challenges in Utilizing ICER to Assess Value of Rare Disease Treatments
Pioneer Institute Discourages Policymakers & Payers from…
https://pioneerinstitute.org/wp-content/uploads/Screen-Shot-2020-06-18-at-8.09.32-PM.png 626 1440 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-04-12 12:29:112021-10-28 12:02:012019 Hewitt Health Care Lecture: U.S. HHS Secretary Alex Azar’s Remarks on Healthcare Price Transparency, Opioid Crisis, HIV Epidemic & More
This past Monday, Pioneer held the 13th annual Hewitt Healthcare…
https://pioneerinstitute.org/wp-content/uploads/GavelSteth.jpg 468 800 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-01-24 06:00:002021-01-28 15:11:06Study Urges Caution Before Adopting ICER Reviews to Determine Cost Effectiveness of Treatments
Review methodology could negatively impact elderly, the disabled,…